Health Canada Signals a Clear Message for Class III & IV Medical Device Applications: Quality Over Volume 

Health Canada has recently published a new Notice to Industry outlining its expectations for information submitted with Class III and Class IV Medical Device Licence Applications (MDLs). The message is clear: more information does not necessarily lead to a better application. In fact, submitting excessive, duplicative, or poorly organized information may slow down the review process and delay market access. 

For medical device manufacturers, this update reinforces the importance of strategic regulatory planning, well-structured evidence packages, and strong regulatory affairs support when preparing Canadian licence applications. 

According to Health Canada, regulators have observed a significant increase in the volume of information being included in Class III and IV licence submissions. While applicants may believe that providing additional documentation strengthens their application, unnecessary content can create challenges for reviewers and extend review timelines. 

Health Canada’s expectation is that manufacturers submit only the information necessary to support the safety, effectiveness, and regulatory compliance of the medical device. Applications should be focused, relevant, and aligned with the requirements outlined in the Medical Devices Regulations.  

For companies seeking efficient approval pathways, this notice serves as an important reminder that regulatory success depends not only on the quality of evidence generated but also on how effectively that evidence is presented. 

Key Expectations for Class III and IV Medical Device Licence Applications 

The notice highlights several important principles for applicants: 

1. Submit Relevant Information Only

Health Canada expects manufacturers to provide the information necessary to support the application and avoid including extraneous documentation that does not directly contribute to demonstrating compliance. Unclear or irrelevant information may result in requests for clarification and longer review times. 

2. Provide Clear and Concise Summaries

The Medical Devices Regulations require applicants to include summaries of studies and supporting evidence. Health Canada emphasizes that these summaries should: 

• Be clear and concise 

• Accurately reflect underlying data 

• Clearly identify information that supports regulatory review and decision-making  

3. Ensure Supporting Evidence is Well Organized

Reviewers should be able to readily locate and understand the evidence being referenced. Well-structured submissions can help facilitate a more efficient review process and minimize questions during screening and evaluation.  

4. Maintain Responsibility When Using AI-Generated Content

Health Canada specifically addresses the use of artificial intelligence tools in regulatory submissions. While AI may assist with generating summaries or explanatory text, applicants remain fully responsible for ensuring that all content is accurate and faithfully represents the supporting evidence. 

Common Challenges Dell Tech Sees in Medical Device Licence Applications 

From a regulatory consulting perspective, many submission deficiencies stem from issues such as: 

• Overly lengthy clinical or performance evidence summaries 

• Duplicative documentation submitted across multiple sections 

• Inconsistent references between reports and summaries 

• Inadequate justification for device claims 

• Poorly organized technical documentation 

• Insufficient linkage between evidence and regulatory requirements 

These challenges can increase review complexity and lead to additional information requests, extending approval timelines. 

How can Manufacturers Prepare for filing a Class III / IV Medical Device License Application? 

Sponsors should consider: 

• Review Submission Content Critically – Ask whether each document directly supports the regulatory requirements for the device. If the relevance isn’t obvious, additional explanation—or removal—may be warranted. 
• Focus on Evidence Quality- Strong submissions demonstrate safety and effectiveness through relevant, scientifically justified evidence rather than sheer document volume. 
• Strengthen Regulatory Writing- Technical summaries should be concise, accurate, and written specifically for regulatory reviewers. 
• Conduct Pre-Submission Gap Assessments- An independent review can identify areas where documentation may be excessive, incomplete, or misaligned with Health Canada expectations before submission. 

Dell Tech can help with Medical Device License Applications 

The Health Canada notice reinforces the value of experienced regulatory affairs support to help with:  

• Preparing Class III and Class IV Medical Device Licence Applications 

• Developing regulatory strategies for Canadian market access 

• Conducting submission gap assessments 

• Reviewing clinical, efficacy, safety, and quality evidence packages 

• Creating compliant technical documentation and summaries 

• Responding to Health Canada information requests 

• Supporting quality management system compliance under ISO 13485: 2016 under MDSAP 

• Navigating Health Canada Medical Device Regulations  

By focusing on submission quality, relevance, and regulatory alignment, manufacturers can reduce avoidable delays and improve the likelihood of a smoother review process. 

Source: Health Canada, Expectations for Information Submitted with Class III and IV Medical Device Licence Applications: Notice to Industry (July 16, 2026)